In March 2024, a scoping review of 15 clinical trials, six case reports and one retrospective cohort study, published in the Journal of the American Academy of Dermatology reported that dysaesthesia occurred in 6 of 334 participants (1.8%) taking semaglutide and not in any patients taking placebo
The user administered 2 mg of semaglutide on the day her symptoms transpired
Besides the most obvious positive side effect which is weight loss, other effects can improve your overall health long-term with improvements in blood pressure, reduced blood sugar levels in those with type 1 diabetes, and improvements in cardiovascular health from improved mobility and changes in exercise
Despite these limitations, this study validates the safety of combined cagrilintide and semaglutide pharmacotherapy, justifying additional studies to evaluate efficacy for weight management in obesity
Make sure the 0 icon is visible in the dose window before removing the needle from the skin